Resveratrol, a bioflavonoid, improves diabetes in diabetic rodents when they ingest it orally. This has been substantiated by various research studies. But there was very little known how these beneficial changes are mediated in rodent’s body. Now there is evidence from a new study that answers that question. Endocrinology, journal of The Endocrinology Society, reports the brain has a key role in mediating resveratrol’s anti-diabetic actions. This finding is potentially pointing the direction for future orally-delivered diabetes medications which target the brain. Read the rest of this entry »